Admission Date:  [**2192-8-8**]              Discharge Date:   [**2192-8-16**]  Date of Birth:  [**2140-11-22**]             Sex:   M  Service: CARDIOTHORACIC  Allergies: Pollen Extracts / Bee Pollens  Attending:[**First Name3 (LF) 1283**] Chief Complaint: Decreased vision in left eye  Major Surgical or Invasive Procedure: Redo Mitral valve replacement  History of Present Illness: Mr [**Known lastname 66797**] is a 51 year old man who under went minimally invasive mitral valve replacement on [**2192-6-27**].
He had cough with sputum that his primary care physician treated with zithromax.
Admitted for redo mitral valve replacement  Past Medical History: Mitral Valve Prolapse Strepococcus endocarditis [**9-12**] Hypertension Hyperlipidemia [**First Name9 (NamePattern2) 66798**] [**Location (un) **] [**2170**] - no residual S/P Mitral Valve Replacement [**6-14**] S/P Right Knee Surgery [**2191**] S/P Oral Surgery [**2191**] S/P Vasectomy S/P Tonsillectomy and Adenoids  Social History: He works as a consultant and lives with his wife.
Physical Exam: Preop: Vitals: Blood pressure 143/88, Heart Rate 88, Respiratory Rate 28, Oxygen Saturation 97% on room air, Temperature 97.2 General: well developed male in no acute distress HEENT: oropharynx benign, Neck: supple, no JVD, Heart: regular rate, normal s1s2, Systolic murmur Lungs: clear bilaterally Abdomen: soft, nontender, normoactive bowel sounds Ext: warm, well perfused Neuro: nonfocal  Discharge: Vitals: T 99.4, BP 110/55, HR 100, RR 18 O2 Sat 95% on RA General: well developed male in no acute distress HEENT: oropharynx benign, Neck: normal range of motion, no JVD, Lungs: clear bilaterally anterior and posterior Heart: regular rate, normal s1s2 no murmur/rub/gallop Abdomen: soft, nontender, normoactive bowel sounds Ext: warm, well perfused Neuro: nonfocal Psychiatric: pleasant and appropriate  Pertinent Results: [**2192-8-16**] 07:20AM BLOOD WBC-14.9* RBC-3.58* Hgb-10.2* Hct-29.6* MCV-83 MCH-28.5 MCHC-34.4 RDW-14.9 Plt Ct-500* [**2192-8-14**] 03:11AM BLOOD PT-12.0 PTT-24.5 INR(PT)-1.0 [**2192-8-16**] 07:20AM BLOOD Glucose-140* UreaN-26* Creat-1.0 Na-135 K-4.3 Cl-95* HCO3-29 AnGap-15  CHEST (PA & LAT)  [**2192-8-16**] 9:46 AM  CHEST (PA & LAT)  Reason: atelectasis improving?
INDICATION: Status post mitral valve replacement.
The patient is status post median sternotomy and mitral valve surgery.
LV WALL MOTION: basal anterior - normal; mid anterior - normal; basal anteroseptal - normal; mid anteroseptal - normal; basal inferoseptal - normal; mid inferoseptal - normal; basal inferior - normal; mid inferior - normal; basal inferolateral - normal; mid inferolateral - normal; basal anterolateral - normal; mid anterolateral - normal; anterior apex - normal; septal apex - normal; inferior apex - normal; lateral apex - normal; apex - normal;  RIGHT VENTRICLE: Normal RV chamber size and free wall motion.
MITRAL VALVE: Bioprosthetic mitral valve prosthesis (MVR).
The TEE probe was passed with assistance from the  anesthesioology staff using a laryngoscope.
The patient was under general anesthesia throughout the procedure.
A bioprosthetic mitral valve prosthesis is present.
It was associated with a calculated mitral valve area of 0.9cm2.
He tolerated the operation well and was transferred to the cardiac surgery recovery unit.
At the time of transfer he was on epinephrine, neosynephrine, and propofol.
He did well in the immediate post operative period and was weaned from the epinephrine, neosynephrine, and propofol.
The anesthesia was reversed and he was successfully weaned from the ventilator and extubated.
On post operative day 1, he remained in the cardiac surgery recovery unit for aggressive diuresis, pain management and management of hypertension.
On postoperative day [**1-15**], continued with aggressive diuresis, transfused with packed red blood cell for hematocrit 21, pain management, chest tube and epicardial wires removed.
He also required aggressive respiratory therapy.
Medications on Admission: Lopressor 50mg twice a day Aspirin 325mg twice a day Lipitor 40mg daily Zitromax - completed just prior to admission  Discharge Medications: 1.
Potassium Chloride 10 mEq Capsule, Sustained Release Sig: Two (2) Capsule, Sustained Release PO twice a day: 20 meq [**Hospital1 **] x 1week then 20meq QD x 10 days.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Atorvastatin 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Hydromorphone 2 mg Tablet Sig: 1-2 Tablets PO Q3-4H (Every 3 to 4 Hours) as needed.
Lasix 40 mg Tablet Sig: One (1) Tablet PO twice a day: 40 mg [**Hospital1 **] x 7 days then 40mg QD x10 days.
Protonix 40 mg Tablet, Delayed Release (E.C.)
Glucosamine 500 mg Tablet Sig: as directed Tablet PO once a day: resume preop schedule.
Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO three times a day.
Keflex 500 mg Capsule Sig: One (1) Capsule PO four times a day for 6 days.
Disp:*24 Capsule(s)* Refills:*0*   Discharge Disposition: Home With Service  Facility: [**Location (un) 1110**] VNA  Discharge Diagnosis: Redo Mitral valve replacement (#29 CE pericardial) PMH: Mitral valve prolapse, Mitral valve replacement, s/p [**Location (un) 30065**]-[**Location (un) **] '[**70**], Hypertension, elevated cholesterol, Endocarditis, Right knee [**Doctor First Name **], Tonsillectomy and adenoids, Vasectomy  Discharge Condition: good   Discharge Instructions: Keep wounds clean and dry.
Take all medications as prescribed.
